These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 26916231)
1. Synthesis of 2-(methylsulfonyl)-5-(4-(methylsulfonyl) phenyl)-4-phenyl-1H-[5-(14)C]imidazole, a selective COX-2 inhibitor, via asymmetrical benzoins. Shirvani G; Shockravi A; Amini M; Saemian N J Labelled Comp Radiopharm; 2016 Apr; 59(4):153-6. PubMed ID: 26916231 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of new (E)- and (Z)-1,2,3-triaryl-2-propen-1-ones as selective COX-2 inhibitors. Arfaie S; Zarghi A Eur J Med Chem; 2010 Sep; 45(9):4013-7. PubMed ID: 20691338 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors. Chen QH; Rao PN; Knaus EE Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors. Navidpour L; Amini M; Shafaroodi H; Abdi K; Ghahremani MH; Dehpour AR; Shafiee A Bioorg Med Chem Lett; 2006 Sep; 16(17):4483-7. PubMed ID: 16806914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]